Dual drugs (microRNA-34a and paclitaxel)-loaded functional solid lipid nanoparticles for synergistic cancer cell suppression

Journal of Controlled Release

Volumn 194, Issue , 2014, Pages 228-237

  Shi, Sanjun ^a   Han, Lu ^a   Deng, Li ^a   Zhang, Yanling ^a   Shen, Hongxin ^a   Gong, Tao ^a   Zhang, Zhirong ^a   Sun, Xun ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Co delivery; MicroRNA; Paclitaxel; Synergistic cancer suppression; Tumor relapse

Indexed keywords

CANCER CELLS; CO DELIVERIES; MICRORNAS; PACLITAXEL; SOLID LIPID NANOPARTICLE (SLN); SYNERGISTIC CANCER SUPPRESSION;

CD44V ANTIGEN; MICRORNA 34A; PACLITAXEL; SOLID LIPID NANOPARTICLE; ANTINEOPLASTIC AGENT; HERMES ANTIGEN; MICRORNA; MIRN34 MICRORNA, HUMAN; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER RECURRENCE; CANCER THERAPY; CARCINOGENICITY; CELL POPULATION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG POTENCY; GROWTH INHIBITION; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; LUNG METASTASIS; LUNG PARENCHYMA; MELANOMA; METASTASIS; MOUSE; NANOENCAPSULATION; NEOPLASM; NONHUMAN; PHOTON CORRELATION SPECTROSCOPY; SERUM; TUMOR GROWTH; ANIMAL; APOPTOSIS; CELL PROLIFERATION; DRUG DESIGN; DRUG EFFECTS; DRUG POTENTIATION; GENETICS; HUMAN; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ANIMALS; ANTIGENS, CD44; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG DELIVERY SYSTEMS; DRUG DESIGN; DRUG SYNERGISM; HUMANS; MICE; MICRORNAS; NANOPARTICLES; PACLITAXEL; TISSUE DISTRIBUTION;

EID: 84907226801     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.09.005     Document Type: Article

References (31)

1. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
2. J. Lu, G. Getz, E.A. Miska, E. Alvarez-Saavedra, J. Lamb, D. Peck, A. Sweet-Cordero, B.L. Ebert, R.H. Mak, A.A. Ferrando, J.R. Downing, T. Jacks, H.R. Horvitz, and T.R. Golub MicroRNA expression profiles classify human cancers Nature 435 2005 834 838
3. V. Ambros The functions of animal microRNAs Nature 431 2004 350 355
4. R.I. Gregory, and R. Shiekhattar MicroRNA biogenesis and cancer Cancer Res. 65 2005 3509 3512
5. K. Tahara, H. Yamamoto, N. Hirashima, and Y. Kawashima Chitosan-modified poly(d, l-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects Eur. J. Pharm. Biopharm. 74 3 2010 421 426
6. P. Fasanaro, S. Greco, M. Ivan, M.C. Capogrossi, and F. Martelli microRNA: emerging therapeutic targets in acute ischemic diseases Pharmacol. Ther. 125 2010 92 104
7. A.G. Bader, D. Brown, and M. Winkler The promise of microRNA replacement therapy Cancer Res. 70 2010 7027 7030
8. C. Zhang, R. Mo, B. Yin, L. Zhou, Y. Liu, and J. Fan Tumor suppressor microRNA-34a inhibits cell proliferation by targeting Notch1 in renal cell carcinoma Oncol. Lett. 7 2014 1689 1694
9. X.J. Li, Z.J. Ren, and J.H. Tang MicroRNA-34a: a potential therapeutic target in human cancer Cell Death Dis. 5 2014 e1327
10. B. Joshua, M.J. Kaplan, I. Doweck, R. Pai, I.L. Weissman, M.E. Prince, and L.E. Ailles Frequency of cells expressing CD44, a head and neck cancer stem cell marker: correlation with tumor aggressiveness Head Neck 34 2012 42 49
11. C. Liu, K. Kelnar, B. Liu, X. Chen, T. Calhoun-Davis, H. Li, L. Patrawala, H. Yan, C. Jeter, S. Honorio, J.F. Wiggins, A.G. Bader, R. Fagin, D. Brown, and D.G. Tang The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44 Nat. Med. 17 2011 211 215
12. P. Bu, K.Y. Chen, J.H. Chen, L. Wang, J. Walters, Y.J. Shin, J.P. Goerger, J. Sun, M. Witherspoon, N. Rakhilin, J. Li, H. Yang, J. Milsom, S. Lee, W. Zipfel, M.M. Jin, Z.H. Gumus, S.M. Lipkin, and X. Shen A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells Cell Stem Cell 12 2013 602 615
13. Y. Chen, X. Zhu, X. Zhang, B. Liu, and L. Huang Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy Mol. Ther. 18 2010 1650 1656
14. S. Shi, L. Han, T. Gong, Z. Zhang, and X. Sun Systemic delivery of microRNA-34a for cancer stem cell therapy Angew. Chem. Int. Ed. Engl. 52 2013 3901 3905
15. M.E. Wall, and M.C. Wani Camptothecin and taxol: from discovery to clinic J. Ethnopharmacol. 51 1996 239 254
16. G. Cavallaro, M. Licciardi, P. Caliceti, S. Salmaso, and G. Giammona Synthesis, physico-chemical and biological characterization of a paclitaxel macromolecular prodrug Eur. J. Pharm. Biopharm. 58 2004 151 159
17. B. Zhang, X. Sun, H. Mei, Y. Wang, Z. Liao, J. Chen, Q. Zhang, Y. Hu, Z. Pang, and X. Jiang LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma Biomaterials 34 2013 9171 9182
18. A. Roy, M.S. Singh, P. Upadhyay, and S. Bhaskar Nanoparticle mediated co-delivery of paclitaxel and a TLR-4 agonist results in tumor regression and enhanced immune response in the tumor microenvironment of a mouse model Int. J. Pharm. 445 2013 171 180
19. J. Shen, Q. Yin, L. Chen, Z. Zhang, and Y. Li Co-delivery of paclitaxel and survivin shRNA by pluronic P85-PEI/TPGS complex nanoparticles to overcome drug resistance in lung cancer Biomaterials 33 2012 8613 8624
20. S. Emanuele, M. Lauricella, D. Carlisi, B. Vassallo, A. D'Anneo, P. Di Fazio, R. Vento, and G. Tesoriere SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor bortezomib Apoptosis 12 2007 1327 1338
21. R. Galli, E. Binda, U. Orfanelli, B. Cipelletti, A. Gritti, S. De Vitis, R. Fiocco, C. Foroni, F. Dimeco, and A. Vescovi Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma Cancer Res. 64 2004 7011 7021
22. Y. Shimono, M. Zabala, R.W. Cho, N. Lobo, P. Dalerba, D. Qian, M. Diehn, H. Liu, S.P. Panula, E. Chiao, F.M. Dirbas, G. Somlo, R.A. Pera, K. Lao, and M.F. Clarke Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells Cell 138 2009 592 603
23. H. Xin, L. Chen, J. Gu, X. Ren, Z. Wei, J. Luo, Y. Chen, X. Jiang, X. Sha, and X. Fang Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(varepsilon-caprolactone) nanoparticles: in vitro and in vivo evaluation Int. J. Pharm. 402 2010 238 247
24. M. Yamakuchi, M. Ferlito, and C.J. Lowenstein miR-34a repression of SIRT1 regulates apoptosis Proc. Natl. Acad. Sci. U. S. A. 105 2008 13421 13426
25. Y. Li, F. Guessous, Y. Zhang, C. Dipierro, B. Kefas, E. Johnson, L. Marcinkiewicz, J. Jiang, Y. Yang, T.D. Schmittgen, B. Lopes, D. Schiff, B. Purow, and R. Abounader MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes Cancer Res. 69 2009 7569 7576
26. R.T.K. Pang, C.O.N. Leung, T.M. Ye, W.M. Liu, P.C.N. Chiu, K.K.W. Lam, K.F. Lee, and W.S.B. Yeung MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells Carcinogenesis 31 2010 1037 1044
27. K. Kojima, Y. Fujita, Y. Nozawa, T. Deguchi, and M. Ito MiR-34a attenuates paclitaxel-resistance of hormone-refractory prostate cancer PC3 cells through direct and indirect mechanisms Prostate 70 2010 1501 1512
28. P. de Antonellis, C. Medaglia, E. Cusanelli, I. Andolfo, L. Liguori, G. De Vita, M. Carotenuto, A. Bello, F. Formiggini, A. Galeone, G. De Rosa, A. Virgilio, I. Scognamiglio, M. Sciro, G. Basso, J.H. Schulte, G. Cinalli, A. Iolascon, and M. Zollo MiR-34a targeting of Notch ligand delta-like 1 impairs CD15 +/CD133 + tumor-propagating cells and supports neural differentiation in medulloblastoma PLoS One 6 2011 e24584
29. C.P. Hollis, H.L. Weiss, M. Leggas, B.M. Evers, R.A. Gemeinhart, and T. Li Biodistribution and bioimaging studies of hybrid paclitaxel nanocrystals: lessons learned of the EPR effect and image-guided drug delivery J. Control. Release 172 2013 12 21
30. H. Maeda, H. Nakamura, and J. Fang The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo Adv. Drug Deliv. Rev. 65 2013 71 79
31. W. Zhang, Y. Shi, Y.Z. Chen, J.G. Hao, X.Y. Sha, and X.L. Fang The potential of pluronic polymeric micelles encapsulated with paclitaxel for the treatment of melanoma using subcutaneous and pulmonary metastatic mice models Biomaterials 32 2011 5934 5944